Athanasios Simoulis (Former)
1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Outcome prediction of prostate cancer patients on active surveillance using weakly supervised deep learning
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
- 2024
-
Mark
Artificial intelligence for detection of prostate cancer in biopsies during active surveillance
- Contribution to journal › Article
- 2023
-
Mark
Systematic Augmentation in HSV Space for Semantic Segmentation of Prostate Biopsies
(2023) 22nd Scandinavian Conference on Image Analysis, SCIA 2023 In Lecture Notes in Computer Science 13886. p.293-308
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
FDG-PET/CT for lymph node staging prior to radical cystectomy
- Contribution to journal › Article
-
Mark
Urodrill - a novel MRI-guided endoscopic biopsy technique to sample and molecularly classify muscle-invasive bladder cancer without fractionating the specimen during transurethral resection
- Contribution to journal › Article
- 2022
-
Mark
FcγRIIIa receptor interacts with androgen receptor and PIP5K1α to promote growth and metastasis of prostate cancer
- Contribution to journal › Article
-
Mark
Bladder cancer recurrence in papillary urothelial neoplasm of low malignant potential (PUNLMP) compared to G1 WHO 1999 : a population-based study
- Contribution to journal › Article
-
Mark
Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
- Contribution to journal › Article
-
Mark
Assessing the accuracy of [18F]PSMA-1007 PET/CT for primary staging of lymph node metastases in intermediate- and high-risk prostate cancer patients
- Contribution to journal › Article
- 2021
-
Mark
Targeted inhibition of ERα signaling and PIP5K1α/Akt pathways in castration-resistant prostate cancer
- Contribution to journal › Article
